Forbes January 3, 2024
Alex Knapp

Beijing-based tech giant ByteDance, better known as the parent company of social media platform TikTok, is recruiting scientists in a variety of fields for AI-based research into drug discovery and other scientific endeavors, according to reporting from our colleague Alexandra Levine. It’s not clear exactly how drug discovery fits into the company’s overall strategy, but it’s already published research on protein and drug design. It’s also released an open source AI tool for computational biology.

Read the whole story here.

How This Startup Is Using 10 Million Patient Records To Reduce Bias In Health AI

While the Biden administration grapples with how to keep up with the fast-changing technology, Dandelion Health is trying to fill the void with a de-identified...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Social Media, Technology
Akiko Iwasaki: The Immunology of Covid and the Future
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
GLP-1 Agonists May One Day Treat Prostate Cancer
Amgen shares soar as executives outline obesity drug push
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

Share This Article